TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Opthea Limited Sponsored ADR ( (OPT) ) has issued an announcement.
On November 11, 2025, Opthea Limited held its Annual General Meeting in Melbourne, Australia, where all resolutions presented to shareholders were approved by the necessary majority. The successful passage of these resolutions, including the re-election of directors and the issuance of options, reflects shareholder confidence in the company’s strategic direction and leadership, potentially strengthening its position in the biotechnology sector.
The most recent analyst rating on (OPT) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Opthea Limited Sponsored ADR stock, see the OPT Stock Forecast page.
Spark’s Take on OPT Stock
According to Spark, TipRanks’ AI Analyst, OPT is a Underperform.
Opthea Limited’s stock is currently rated low due to significant financial challenges, including persistent losses, high leverage, and poor cash flow management. The technical analysis indicates a bearish trend with no immediate recovery signals. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, suggesting limited appeal to investors seeking growth or income. The stock’s high beta adds to the risk profile, emphasizing the need for strategic improvements to enhance financial performance.
To see Spark’s full report on OPT stock, click here.
More about Opthea Limited Sponsored ADR
Opthea Limited operates in the biotechnology industry, focusing on the development of therapies for eye diseases. The company is known for its work in advancing treatments for conditions such as wet age-related macular degeneration, targeting significant unmet needs in ophthalmology.
Technical Sentiment Signal: Sell
Current Market Cap: $482M
Find detailed analytics on OPT stock on TipRanks’ Stock Analysis page.